The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Open accessAbstract
Nucleoside reverse transcriptase inhibitors (NRTIs) are mainstay therapeutics for HIV that block retrovirus replication. Alu (an endogenous retroelement that also requires reverse transcriptase for its life cycle)–derived RNAs activate P2X7 and the NLRP3 inflammasome to cause cell death of the retinal pigment epithelium in geographic atrophy, a type of age-related macular degeneration. We found that NRTIs inhibit P2X7-mediated NLRP3 inflammasome activation independent of reverse transcriptase inhibition. Multiple approved and clinically relevant NRTIs prevented caspase-1 activation, the effector of the NLRP3 inflammasome, induced by Alu RNA. NRTIs were efficacious in mouse models of geographic atrophy, choroidal neovascularization, graft-versus-host disease, and sterile liver inflammation. Our findings suggest that NRTIs are ripe for drug repurposing in P2X7-driven diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ensuing IFN-I and inflammatory responses were mitigated by treatment with NRTIs95, 129.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [129]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Another possibility is the reported anti-inflammatory property of NRTIs to alleviate activation of the NLRP3 inflammasome without engaging reverse transcriptase129.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,197
Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D. A., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,154
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrı́n, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,490
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Rathinam, V. A. K., Jiang, Z., Waggoner, S. N., Sharma, S., Cole, L. E., Waggoner, L., Vanaja, S. K., Monks, B. G., Ganesan, S., Latz, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1864 · Cited by 1,331
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2013) · Nature · doi:10.1038/nature12940 · Cited by 1,216
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210
Self-citationFranchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–220 of 220
Inflammatory target of antiretroviral drugs
Minton, K. (2014) · Nature reviews. Immunology · doi:10.1038/nri3791
Ambati, J. (2017) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126416683850
Self-citationTHE EFFECT OF HAART ON LIVER DISEASE PROGRESSION IN HIV INFECTION
Price, J. C. (2015)
Markitantova, Y. V., & Simirskii, V. N. (2021) · Russian Journal of Developmental Biology · doi:10.1134/s1062360421060084 · Cited by 1
Zhang, M., & Xuan, Z. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735010803.793558596
(2015) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2015.03.004
Pieters, J., & Mode, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735010803.793558622
Involvement of the Purinergic System in Cell Death in Models of Retinopathies
Cruz, D. P., Repossi, M. G., & Madeira, L. F. (2022) · Biochemistry · doi:10.5772/intechopen.103935
Inflammasomes in the pathobiology of degenerative retinopathies
Silke, E., Cahill, M. T., Campbell, M., & Doyle, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00021-9 · Cited by 1
Niemczak, C. E., Zhan, Y., Ren, J., Song, F., Lu, H., Chen, G., Fellows, A. M., Gui, J., Soli, S. D., Buckey, J. C., et al. (2023) · International Journal of Audiology · doi:10.1080/14992027.2023.2168217
Callyspongia sp. : Metabolit Sekunder, Aktivitas farmakologi, dan Mekanismenya
Nurhaniefah, A. A., Sagitasa, S., Aulia, S., & Hadisaputri, Y. E. (2022) · Indonesian Journal of Biological Pharmacy · doi:10.24198/ijbp.v2i2.39891
Response to ‘Early Onset Drusen and RPE Dysfunction in a Patient with NLRP3-AID’
Ambati, J., & Gelfand, B. D. (2023) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2023.2191710
Self-citationFerrari, I. V. (2023) · Preprints.org · doi:10.20944/preprints202312.0806.v1
Target Nlrp3 Inflammasome Signaling for Atrial Fibrillation TherapyPreprint
Lu, W., Huang, L., Lin, W., Sun, Y., Chen, L., Yang, P., Zhang, S., Wang, Z., Liu, Y., Cao, L., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4879402
NLRP3 Activation With Bisphosphonate Use and the Risk of Incident Age-Related Macular Degeneration
Magagnoli, J., Cummings, T. H., Hardin, J. W., Sutton, S. S., & Ambati, J. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.3.32
Self-citationTargeting NLRP3 inflammasome signaling for atrial fibrillation therapy
Liu, Y., Zhou, L., Lin, W., Huang, L., Cao, L., Zou, X., Lu, J., Yang, J., Zhao, K., Lu, J., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119222
Hussain, M., Ikram, M., & Vohora, D. (2026) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70079
Potential impacts of antivirals on the virome
Jin, Y., Zhao, J., & Zuo, T. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.04.005
Zhang, Y., Zhang, X., Huang, J., & Sun, Z. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112014
Nigro, A. (2026) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2026.2725840
Metadata
- Authors
- Fowler, B. J., Gelfand, B. D., Kim, Y., Kerur, N., Tarallo, V., Hirano, Y., Amarnath, S., Fowler, D. H., Radwan, M., Young, M. T., Pittman, K., Kubes, P., Agarwal, H. K., Parang, K., Hinton, D. R., Bastos-Carvalho, A., Li, S., Yasuma, T., Mizutani, T., Yasuma, R., Wright, C., & Ambati, J.
- Affiliations
- University of Kentucky (US)
- National Institutes of Health (US)
- Cardiff University (GB)
- University of Calgary (CA)
- Chapman University (US)
- University of Southern California (US)
- Corresponding author
- Ambati, Jayakrishna
- ORCID
- Venue
- Science
- Published
- 2014-11-21
- Volume
- 346
- Issue
- 6212
- Pages
- 1000-1003
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4274127
- OpenAlex
- W2058803210
- Cited by
- 225
- References
- 48
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 15 · 2023: 17 · 2022: 19 · 2021: 24 · 2020: 16 · 2019: 20 · 2018: 19 · 2017: 26 · 2016: 21 · 2015: 23 · 2014: 1
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Chapman University Digital Commons (Chapman University) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- National Institutes of Health (TL1TR000115, 1ul1rr033173-01, UL1TR000117)
- Biotechnology and Biological Sciences Research Council (BB/J017345/1)
- National Heart, Lung, and Blood Institute (T32HL091812)
- National Eye Institute (R01EY020672, P30EY003040, R01EY018836, R01EY001545, R01EY018350, R00EY024336, R01EY024068, R01EY022238, K99EY024336)
- National Institute of General Medical Sciences (DP1GM114862)
- National Center for Research Resources (UL1RR-033173, TL1RR033172)
- National Center for Chronic Disease Prevention and Health Promotion (DP1GM114862)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- nucleoside reverse transcriptase inhibitors, anti-inflammatory activity, P2X7 receptor, NLRP3 inflammasome, Alu RNA, geographic atrophy, age-related macular degeneration, retinal pigment epithelium, caspase-1 activation, choroidal neovascularization, graft-versus-host disease, drug repurposing, HIV treatment
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Anti-Inflammatory Agents, Non-Steroidal, Carrier Proteins, Disease Models, Animal, Graft vs Host Disease, Hepatitis, Liver, Apoptosis, Reverse Transcriptase Inhibitors, Alu Elements, Caspase 1, Choroidal Neovascularization, Mice, Retinal Pigment Epithelium, Geographic Atrophy, Receptors, Purinergic P2X7, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
